CD4 and cancer: Genes altered in Yap-cKO TILs were also significantly associated with patient survival across several cancers (Fig 4J), as seen most significantly in LUAD for both CD4+ and CD8+ Yap-cKO gene signatures (Fig 4K and 4L).